What is it about?
We developed a material combining chitosan, polyethylene glycol, and doxycycline to deliver antibiotics locally for gum disease. Laboratory tests showed antibacterial activity and antibiotic release lasting over 10 hours, offering a promising approach for future periodontal treatments.
Featured Image
Photo by Evgeniy Kozlov on Unsplash
Why is it important?
This study introduces a novel xerogel-based system combining acidified chitosan, polyethylene glycol, and doxycycline hyclate for localized antibiotic delivery in periodontal disease. Its key innovation is the ability to sustain antibiotic release for more than 10 hours, supported by comprehensive physicochemical characterization, drug-release modelling, and laboratory antibacterial testing. The formulation also uses a solvent-casting approach with drying under ambient conditions, offering a potentially straightforward route to fabrication. The work is timely because it addresses an important challenge in periodontal therapy: delivering antimicrobial agents locally while controlling their release and potentially limiting unnecessary systemic exposure. By integrating biopolymer-based material design with drug-release evaluation and computational predictions of pharmacokinetic properties, this research provides a foundation for further development of localized periodontal drug-delivery systems. The findings may inform future efforts to improve treatment delivery, although clinical effectiveness, safety, and performance in the periodontal environment require further investigation.
Perspectives
As a dental academician and researcher working at the interface of dental biomaterials, implantology, and pharmaceutical sciences, I believe that meaningful advances in dentistry often emerge from combining knowledge across disciplines. This publication reflects my interest in translating biomaterial science into practical approaches that address persistent clinical challenges. What particularly motivates me about this work is the opportunity to explore how a locally applied, biopolymer-based material can provide controlled antibiotic delivery for periodontal disease. Developing and characterizing these xerogels allowed us to investigate not only their physical and chemical properties but also their drug-release behaviour and antibacterial potential. I consider this an important step towards bridging materials research and clinical dentistry. For me, the value of this research lies in its potential to stimulate further innovation in localized drug delivery. Although additional biological, preclinical, and clinical studies are needed before therapeutic benefits can be established, I hope this work encourages collaboration among dental researchers, biomaterial scientists, and pharmaceutical formulators to develop safer, more targeted, and more effective periodontal treatment strategies.
Farjad Zafar
Baqai Medical University
Read the Original
This page is a summary of: Novel Antibiotic-Loaded PEGylated Xerogels of Acidified Chitosan for Periodontal Diseases, Current Drug Delivery, August 2026, Bentham Science Publishers,
DOI: 10.2174/0115672018377472250326061736.
You can read the full text:
Resources
Contributors
The following have contributed to this page
